Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
- Authors
- Bloom, A Joseph; Hartz, Sarah M; Baker, Timothy B; Chen, Li-Shiun; Piper, Megan E; Fox, Louis; Martinez, Maribel; Hatsukami, Dorothy; Johnson, Eric O; Laurie, Cathy C; Saccone, Nancy L; Goate, Alison; Bierut, Laura J
- Year
- 2014
- Journal
- Annals of the American Thoracic Society
- PMID
- 25072098
- DOI
- 10.1513/AnnalsATS.201401-010OC
- PMCID
- PMC4214060
RATIONALE: The CHRNA5-CHRNA3-CHRNB4 locus is associated with self-reported smoking behavior and also harbors the strongest genetic associations with chronic obstructive pulmonary disease (COPD) and lung cancer. Because the associations with lung disease remain after adjustment for self-reported smoking behaviors, it has been asserted that CHRNA5-CHRNA3-CHRNB4 variants increase COPD and lung cancer susceptibility independently of their effects on smoking. OBJECTIVES: To compare the genetic associations of exhaled carbon monoxide (CO), a biomarker of current cigarette exposure, with self-reported smoking behaviors. METHODS: A total of 1,521 European American and 247 African American current smokers recruited into smoking cessation studies were assessed for CO at intake before smoking cessation. DNA samples were genotyped using the Illumina Omni2.5 microarray. Genetic associations with CO and smoking behaviors (cigarettes smoked per day, Fagerstrom test for nicotine dependence) were studied. MEASUREMENTS AND MAIN RESULTS: Variants in the CHRNA5-CHRNA3-CHRNB4 locus, including rs16969968, a nonsynonymous variant in CHRNA5, are genomewide association study-significantly associated with CO (Ξ² = 2.66; 95% confidence interval [CI], 1.74-3.58; P = 1.65 Γ 10(-8)), and this association remains strong after adjusting for smoking behavior (Ξ² = 2.18; 95% CI, 1.32-3.04; P = 7.47 Γ 10(-7)). The correlation between CO and cigarettes per day is statistically significantly lower (z = 3.43; P = 6.07 Γ 10(-4)) in African Americans (r = 0.14; 95% CI, 0.02-0.26; P = 0.003) than in European-Americans (r = 0.36; 95% CI, 0.31-0.40; P = 0.0001). CONCLUSIONS: Exhaled CO, a biomarker that is simple to measure, captures aspects of cigarette smoke exposure in current smokers beyond the number of cigarettes smoked per day. Behavioral measures of smoking are therefore insufficient indices of cigarette smoke exposure, suggesting that genetic associations with COPD or lung cancer that persist after adjusting for self-reported smoking behavior may still reflect genetic effects on smoking exposure.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Resting-state functional connectivity and structural differences between smokers and healthy non-smokers. | Weidler C et al. | β | 2024 | β |
| Racial disparities in intensity of smoke exposure and nicotine intake among low-dependence smokers. | Ho JTK et al. | β | 2021 | β |
| Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution. | Icick R et al. | β | 2020 | β |
| Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls. | Lutz SM et al. | β | 2019 | β |
| Effects of Menthol Flavor Cigarettes or Total Urinary Menthol on Biomarkers of Nicotine and Carcinogenic Exposure and Behavioral Measures. | Ahijevych K et al. | β | 2019 | β |
| Clinical and radiographic peri-implant parameters and proinflammatory cytokine levels among cigarette smokers, smokeless tobacco users, and nontobacco users. | Akram Z et al. | β | 2018 | β |
| Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD. | Adams A et al. | β | 2018 | β |
| Effect of antimicrobial photodynamic therapy in open flap debridement in the treatment of peri-implantitis: A randomized controlled trial. | Albaker AM et al. | β | 2018 | β |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | β | 2018 | β |
| Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. | Teitelbaum AM et al. | β | 2018 | β |
| Pathways to precision medicine in smoking cessation treatments. | Chen LS et al. | β | 2018 | β |
| Preparing the Way: Exploiting Genomic Medicine to Stop Smoking. | Bierut LJ et al. | β | 2018 | β |
| The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. | Saccone NL et al. | β | 2018 | β |
| Use of polygenic risk scores of nicotine metabolism in predicting smoking behaviors. | Chen LS et al. | β | 2018 | β |
| A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems. | Richmond-Rakerd LS et al. | β | 2017 | β |
| Genetics of addictive behavior: the example of nicotine dependence. | Gorwood P et al. | β | 2017 | β |
| Pathways to smoking behaviours: biological insights from the Tobacco and Genetics Consortium meta-analysis. | MinicΓ£ CC et al. | β | 2017 | β |
| Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies. | Pintarelli G et al. | β | 2017 | β |
| Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. | Chen LS et al. | β | 2016 | β |
| Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. | Zanetti KA et al. | β | 2016 | β |
| Genome-wide single nucleotide polymorphism heritability of nicotine dependence as a multidimensional phenotype. | Bidwell LC et al. | β | 2016 | β |
| Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. | Olfson E et al. | β | 2016 | β |
| Smokescreen: a targeted genotyping array for addiction research. | Baurley JW et al. | β | 2016 | β |
| The Effect of Different Case Definitions of Current Smoking on the Discovery of Smoking-Related Blood Gene Expression Signatures in Chronic Obstructive Pulmonary Disease. | Obeidat M et al. | β | 2016 | β |
| Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan. | Joshi PK et al. | β | 2016 | β |
| Which measures of cigarette dependence are predictors of smoking cessation during pregnancy? Analysis of data from a randomized controlled trial. | Riaz M et al. | β | 2016 | β |
| CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. | Chen LS et al. | β | 2015 | β |
| Genetic influences on smoking and clinical disease. Understanding behavioral and biological pathways with mediation analysis. | Lutz SM et al. | β | 2014 | β |